Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Philipp A. Ilinykh, Kai Huang, Bronwyn M. Gunn, Natalia A. Kuzmina, Kritika Kedarinath, Eduardo Jurado-Cobena, Fuchun Zhou, Chandru Subramani, Matthew A. Hyde, Jalene V. Velazquez, Lauren E. Williamson, Pavlo Gilchuk, Robert H. Carnahan, Galit Alter, James E. Crowe
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsViral Infections and Outbreaks Research · Hepatitis B Virus Studies
Correction to: Communications Biology 10.1038/s42003-024-06556-0; published online 17 July 2024
In this article, the title was incorrectly given as “Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement“ but should have been “Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system”. The original article has been corrected.